before, medical trials on GLP-1 drugs have proven their Gains as being a secondary prevention Device for heart problems (CVD), this means they can decrease the probability of the coronary heart assault or stroke in https://europeantimes.news/2024/08/belgium-battle-drugs-alcohol-hope/